Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Forte Biosciences Inc (NQ: FBRX )

1.025 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 38
Open 1.025
Bid (Size) 0.9821 (20)
Ask (Size) 1.040 (39)
Prev. Close 1.025
Today's Range 1.025 - 1.025
52wk Range 0.8977 - 1.540
Shares Outstanding 21,051,195
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Scheduled For May 26, 2023
Companies Reporting Before The Bell • LightInTheBox Holding (NYSE:LITB) is estimated to report earnings for its first quarter. 
Via Benzinga
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire

Performance

YTD
-3.30%
-3.30%
1 Month
-2.38%
-2.38%
3 Month
-0.49%
-0.49%
6 Month
+3.19%
+3.19%
1 Year
-13.14%
-13.14%

More News

Read More
Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Mr. David Gryska Appointed to Forte Biosciences Board of Directors
From Forte Biosciences, Inc.
Via Business Wire
Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors
From Forte Biosciences, Inc.
Via Business Wire
Camac Partners Condemns Forte Biosciences’ Seemingly Defensive and Unjustifiable Capital Raise
From Camac Partners, LLC
Via Business Wire
Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Boeing, PriceSmart And 80 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Forte Biosciences, Inc. Announces the Appointment of Dr. Hubert Chen, MD as Chief Scientific Officer and President
From Forte Biosciences, Inc.
Via Business Wire
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
Forte Biosciences, Inc. Announces First Quarter 2022 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
52 Biggest Movers From Friday
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Forte Biosciences, Inc. (NASDAQ:FBRX) Shareholder Notice: Investigation over Potential Wrongdoing
Via SBWire
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.